Science ❯ Medical Research

Vaccine Development

Clinical Trials mRNA Technology Ebola Vaccines Infectious Diseases Epidemiology Immunology COVID-19 Vaccines Clinical Studies Safety Studies Ebola Vaccine

Oxford Administers First Human Dose of Bundibugyo Ebola Vaccine

The phase 1 trial began on July 24 to assess safety and immune response; results could clear the way for field studies in Uganda if regulators agree.

Oxford Launches First Human Trial of Bundibugyo Ebola Vaccine

Ebola Outbreak in DR Congo Reaches 1,406 Cases as WHO Greenlights Treatment Trials

Lancet Review Finds mRNA Vaccines Safe and Highly Effective

Brazil Suspends Butantan Dengue Vaccine After 42 Severe Adverse Reports

CEPI Commits $60 Million to Accelerate Bundibugyo Ebola Vaccines

Rotavirus Spreads Early Across U.S. as Positivity and Wastewater Rise

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Court Freeze of U.S. Vaccine Panel Puts New Shots, Coverage in Limbo

NHS Opens Spring Covid Booster Bookings for Over-75s and Clinically Vulnerable

Covid Inquiry Hails UK Vaccine Rollout, Demands Overhaul of Compensation

Musk’s X Post on Vaccine Reaction Reignites Scrutiny of Covid Vaccines

CDC Vaccine Advisers Pause Push to End mRNA COVID Shot Recommendations

Brazil’s Single-Dose Dengue Vaccine Shows 5-Year Protection as Rollout to Health Workers Begins

RKI’s First IMPRESS Survey Finds Strong Vaccine Support but Low Seasonal Uptake in Germany

Stanford’s Broad-Acting Nasal Vaccine Shows Mouse Success as Human Trials Are Planned

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

Bhattacharya Poised to Lead CDC as Acting Director After Year of RFK Jr. Upheaval

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

Brazil Launches Pilot Dengue Vaccinations With Single‑Dose Butantan Vaccine